Cargando…

Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab

Patients with non-hodgkin lymphomas (NHL) represent a population of special interest during the current Coronavirus disease-19 (COVID-19) pandemics. NHLs are associated with disease- and treatment-related immunodeficiencies which may generate unusual COVID-19 dynamics and pose unique management chal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcacci, Gianpaolo, Fiorentino, Giuseppe, Volzone, Francesco, Falcone, Umberto, Parrella, Roberto, Donnarumma, Daniela, D’Ovidio, Silvia, Annunziata, Anna, Micallo, Giovanni, Portella, Giuseppe, De Chiara, Annarosaria, De Filippi, Rosaria, Crisci, Stefania, Pinto, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170447/ https://www.ncbi.nlm.nih.gov/pubmed/34078415 http://dx.doi.org/10.1186/s13027-021-00376-1

Ejemplares similares

Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation
por: Marcacci, Gianpaolo, et al.
Publicado: (2022)

Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high ‘life threat’ impact cardiopathy
por: Corazzelli, Gaetano, et al.
Publicado: (2011)

Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas
por: Corazzelli, Gaetano, et al.
Publicado: (2011)

Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study
por: De Filippi, Rosaria, et al.
Publicado: (2022)

Hyposecretion of the Adrenal Androgen Dehydroepiandrosterone Sulfate (DHEA-S) in the Majority of the Alopecia Areata Patients: Is it a Primitive and Pathogenic Perturbation of Hypothalamic-Pituitary-Adrenal Axis?
por: d’Ovidio, Roberto, et al.
Publicado: (2011)

Atypical cytologic mantle cell lymphoma presentation
por: Chea, Mathias, et al.
Publicado: (2022)

Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata
por: d’Ovidio, Roberto, et al.
Publicado: (2013)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma
por: Borgerding, Andrea, et al.
Publicado: (2009)

Leuconostoc sp. Meningitis in a Patient Treated with Rituximab for Mantle Cell Lymphoma
por: Holik, Hrvoje, et al.
Publicado: (2015)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
por: Bega, Giulia, et al.
Publicado: (2021)

Rituximab
por: Tridente, Giuseppe
Publicado: (2013)

Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Adashek, Michael, et al.
Publicado: (2018)

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
por: Phillips, Tycel J., et al.
Publicado: (2023)

Successful management of fipronil toxicosis in two pet rabbits
por: d’Ovidio, Dario, et al.
Publicado: (2022)

Primary paraganglioma of the lung: a case report
por: Fiorentino, Giuseppe, et al.
Publicado: (2015)

Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021)

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
por: Villa, Diego, et al.
Publicado: (2022)

Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study
por: Shimizu, Yuki, et al.
Publicado: (2023)

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
por: Yamshon, Samuel, et al.
Publicado: (2023)

Immunosuppressive therapy with rituximab in common variable immunodeficiency
por: Pecoraro, Antonio, et al.
Publicado: (2019)

Self-Rated Health and Psychological Distress among Emerging Adults in Italy: A Comparison between Data on University Students, Young Workers and Working Students Collected through the 2005 and 2013 National Health Surveys
por: Franzoi, Isabella Giulia, et al.
Publicado: (2021)

Sarcoid-Like Reaction in the Kidney Following Rituximab for Mantle Lymphoma in a 60-Year-Old Man
por: Mrabet, Sanda, et al.
Publicado: (2023)

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
por: Fischer, Luca, et al.
Publicado: (2023)

Balance between Health Risks and Benefits for Outdoor Workers Exposed to Solar Radiation: An Overview on the Role of Near Infrared Radiation Alone and in Combination with Other Solar Spectral Bands
por: Grandi, Carlo, et al.
Publicado: (2020)

Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation
por: Filippi, Andrea Riccardo, et al.
Publicado: (2006)

Sleep breathing disorders and nocturnal respiratory pattern in patients with Glycogenosis type II
por: Fiorentino, Giuseppe, et al.
Publicado: (2014)

Effect on lung function of mounthpiece ventilation in Steinert disease. A case report
por: Annunziata, Anna, et al.
Publicado: (2017)

Cancer and Anorexia Nervosa in the Adolescence: A Family-Based Systemic Intervention
por: De Benedetta, Gabriella, et al.
Publicado: (2011)

Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma
por: Annese, Tiziana, et al.
Publicado: (2020)

Alterated integrin expression in lichen planopilaris
por: d'Ovidio, Roberto, et al.
Publicado: (2007)

Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
por: Williams, Jared, et al.
Publicado: (2019)

An Autopsy Case of Misdiagnosed Wernicke's Syndrome after Intragastric Balloon Therapy
por: Vellante, Paola, et al.
Publicado: (2018)

Editorial Comment on Special Issue—COVID-19 after One Year of Clinical Experience: Unexpected Clinical Presentations or Complications and Post-COVID-19 Clinical Features
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA
por: Qu, Chang-Ju, et al.
Publicado: (2023)

An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
por: Darwish, Mona, et al.
Publicado: (2014)

Improvement of the rituximab–induced cell death by potentiation of the store-operated calcium entry in mantle cell lymphoma cell lines
por: Doignon, Isabelle, et al.
Publicado: (2019)

Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
por: Perriello, Vincenzo Maria, et al.
Publicado: (2023)

S1.5 Role of the pulmonologist in the late-onset Pompe disease
por: Fiorentino, Giuseppe, et al.
Publicado: (2011)

MPV promote adherence to nocturnal NIV in a Duchenne patient
por: Annunziata, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jjp5paje3c4d8g2u1jpi7c0t3v